Neuronetics Inc. (STIM) Prices 4.84M Share Common Offering at $15.50/Sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- Wall St slides as oil tops $100, yields hit 2023 high; Apple down before Ternus' first launch event as CEO
- Meta stock jumps 5% premarket: Analysts bullish on new Muse AI agent
- Oil nears $100 as fresh Middle East strikes raise supply risks
- How big a risk are rates to the AI boom?
- 3 reasons why S&P 500 may drop up to 10% in the near term: RBC
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
After-Hours Stock Movers 01/28: (KOSS) (GME) (NVAX) Higher; (EVLO) (ADMP) (JNP) Lower (more...)
January 28, 2021 6:00 PM ESTToday's After-Hours Stock Movers:
Koss Corporation (NASDAQ: KOSS) 47.9% HIGHER; Robinhood will again allow limited trades
GameStop Corp. (NYSE: GME) 35% HIGHER; Robinhood will again allow limited trades
Novavax, Inc. (Nasdaq: NVAX) 29% HIGHER; announced that NVX-CoV2373, its protein-based COVID-19 vaccine candidate, met the primary endpoint, with a vaccine efficacy of 89.3%, in its Phase 3 clinical... More
Neuronetics (STIM) Announces Proposed Public Offering of Common Stock
January 28, 2021 4:02 PM ESTNeuronetics, Inc. (NASDAQ: STIM) (the Company), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has commenced an underwritten public offering of its... More
Neuronetics (STIM) PT Raised to $23 at JMP Securities
January 27, 2021 2:42 AM ESTJMP Securities analyst David Turkaly raised the price target on Neuronetics (NASDAQ: STIM) to $23.00 (from $15.00) while maintaining a Market Outperform rating.... More
